Hederagenin increases apoptosis by suppressing the anti-apoptotic protein Bcl-2 in tumor cells, and it primarily stimulates the mitochondrial endogenous apoptosis pathway by activating polyadenosine diphosphate ribose polymerase, caspase-3, caspase-9, and Bax. The gene discussed is CASP3; the disease is neoplasm.